Ovarian 11β-hydroxysteroid dehydrogenase (11βHSD) activity is suppressed in women with anovulatory polycystic ovary syndrome (PCOS): apparent role for ovarian androgens

J Clin Endocrinol Metab. 2013 Aug;98(8):3375-83. doi: 10.1210/jc.2013-1385. Epub 2013 May 15.

Abstract

Context: Altered hepatic cortisol-cortisone metabolism by type 1 11β-hydroxysteroid dehydrogenase (11βHSD1) has previously been linked with polycystic ovary (PCO) syndrome (PCOS).

Objectives: Our objectives were to establish whether ovarian 11βHSD activities are also altered in PCOS and to determine whether any changes in ovarian cortisol metabolism might reflect exposure to elevated concentrations of insulin or androgens.

Design: Cortisol and cortisone concentrations were measured in follicular fluid aspirated from size-matched follicles dissected from normal, ovulatory, and anovulatory PCOs. Human granulosa-lutein cells, recovered during oocyte retrieval for assisted conception, were maintained in primary culture for 4 days, after which 11βHSD1 activities were measured as the net oxidation of [(3)H]cortisol (100 nmol/L) in the absence and presence of insulin (100 nmol/L) with or without metformin (1 μmol/L) or a range of androgens/oxy-androgen metabolites (0.01-10 μmol/L).

Results: Intrafollicular cortisol to cortisone ratios were elevated in anovulatory PCOs (2.1 ± 0.4, P < .05, n = 13) but did not differ between follicles from ovulatory PCOs (1.6 ± 0.1, n = 24) and normal ovaries (1.2 ± 0.1, n = 14). 11βHSD1 activities were lower in granulosa-lutein cells recovered from patients with PCOS compared with all other causes of infertility (median = 5.8 vs 14.9 pmol cortisone/4 h, respectively; P < .05). Cortisol oxidation was unaffected by insulin with or without metformin, dehydroepiandrosterone, and androstenedione, but was inhibited in a concentration-dependent manner by testosterone, 11β-hydroxyandrostenedione, and 7α- and 7β-hydroxy-dehydroepiandrosterone (P < .01).

Conclusions: There is decreased inactivation of cortisol in follicles from anovulatory PCOS. This may reflect inhibition of 11βHSD1 by androgens and their 7/11-oxy-metabolites, local concentrations of which are increased in PCOS, and may contribute to the block to folliculogenesis seen in PCOS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 11-beta-Hydroxysteroid Dehydrogenases / antagonists & inhibitors*
  • 11-beta-Hydroxysteroid Dehydrogenases / metabolism
  • Adult
  • Androgens / pharmacology*
  • Anovulation / metabolism*
  • Cortisone / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Hydrocortisone / metabolism
  • Infertility, Female / etiology
  • Insulin / pharmacology
  • Metformin / pharmacology
  • Middle Aged
  • Ovary / enzymology*
  • Polycystic Ovary Syndrome / metabolism*

Substances

  • Androgens
  • Insulin
  • Metformin
  • 11-beta-Hydroxysteroid Dehydrogenases
  • Cortisone
  • Hydrocortisone